Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

FDA clears angiotensin II blocker from Ciba

Dec. 31, 1996

Combination antihypertensive product cleared by FDA

Dec. 31, 1996

Bayer launches sustained-release calcium antagonist in U.K.

Dec. 31, 1996

Protein tyrosine kinase inhibitors from Warner-Lambert

Dec. 31, 1996

Beiersdorf-Lilly claims angiotensin II blockers

Dec. 30, 1996

Hyal products for restenosis receive U.S. patent coverage

Dec. 24, 1996

Intercardia and Knoll reach agreement for CHF drug

Dec. 24, 1996

Genzyme commences cardiovascular gene therapy collaboration

Dec. 20, 1996

Dual NEP/ACE inhibitors claimed by Eisai

Dec. 20, 1996

Therapeutically active nicotinic acid esters described by Scotia

Dec. 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....